BIO.B insider filings

BIO-RAD LABORATORIES, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen BIO.B transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
BARRY JAMES — EVP, President, LSG3—1 leg · 1,400 sh · $539,87611
DiVincenzo Jonathan P. — President & COO3—1 leg · 919 sh · $358,8427
ENLOE COURTNEY C — EVP, General Counsel & Sec2—1 leg · 902 sh · $348,3217
Allison Schwartz — Director2——11
SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner2——11
EVRAN SEDAT — EVP, Global Supply Chain2——10
ENGELHARDT EVA ANETTE — EVP, President, CDG1——7
Lakkaraju Roop Kalyan — EVP, Chief Financial Officer1——7
Mehta Rajat — EVP, GBL Commercial Operations1——7

Recent insider filings — BIO-RAD LABORATORIES, INC.

FiledFormInsiderReported transactionsSource
2026-11-124DiVincenzo Jonathan P. — President & COOSale (S): 919 @ $390.47EDGAR
2026-11-124ENLOE COURTNEY C — EVP, General Counsel & SecSale (S): 902 @ $386.17EDGAR
2026-11-124BARRY JAMES — EVP, President, LSGSale (S): 1,400 @ $385.63EDGAR
2026-10-274DiVincenzo Jonathan P. — President & COOOption exercise (M): 1,869 @ $0 · Tax withholding (F): 951 @ $369.95 · Option exercise (M): 1,869 (derivative) @ $0EDGAR
2026-10-224EVRAN SEDAT — EVP, Global Supply ChainOption exercise (M): 1,044 @ $0 · Tax withholding (F): 487 @ $354.50 · Option exercise (M): 1,044 (derivative) @ $0EDGAR
2026-09-094BARRY JAMES — EVP, President, LSGOption exercise (M): 1,027 @ $0 · Tax withholding (F): 369 @ $386.11 · Option exercise (M): 1,056 @ $0 · Tax withholding (F): 470 @ $386.11 · Grant/award (A): 4,313 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 moreEDGAR
2026-09-094Allison Schwartz — DirectorOption exercise (M): 228 @ $0 · Tax withholding (F): 82 @ $386.11 · Option exercise (M): 92 @ $0 · Tax withholding (F): 34 @ $386.11 · Grant/award (A): 719 (derivative) @ $0 · Option exercise (M): 228 (derivative) @ $0 · +1 moreEDGAR
2026-09-094Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerOption exercise (M): 1,370 @ $0 · Tax withholding (F): 559 @ $386.11 · Option exercise (M): 1,536 @ $0 · Tax withholding (F): 782 @ $386.11 · Grant/award (A): 6,326 (derivative) @ $0 · Option exercise (M): 1,370 (derivative) @ $0 · +1 moreEDGAR
2026-09-094Mehta Rajat — EVP, GBL Commercial OperationsOption exercise (M): 456 @ $0 · Tax withholding (F): 233 @ $386.11 · Option exercise (M): 1,370 @ $0 · Tax withholding (F): 504 @ $386.11 · Grant/award (A): 4,601 (derivative) @ $0 · Option exercise (M): 456 (derivative) @ $0 · +1 moreEDGAR
2026-09-094ENLOE COURTNEY C — EVP, General Counsel & SecOption exercise (M): 685 @ $0 · Tax withholding (F): 246 @ $386.11 · Option exercise (M): 768 @ $0 · Tax withholding (F): 305 @ $386.11 · Grant/award (A): 2,876 (derivative) @ $0 · Option exercise (M): 685 (derivative) @ $0 · +1 moreEDGAR
2026-09-094DiVincenzo Jonathan P. — President & COOOption exercise (M): 1,712 @ $0 · Tax withholding (F): 668 @ $386.11 · Grant/award (A): 6,326 (derivative) @ $0 · Option exercise (M): 1,712 (derivative) @ $0EDGAR
2026-09-094ENGELHARDT EVA ANETTE — EVP, President, CDGOption exercise (M): 1,027 @ $0 · Tax withholding (F): 369 @ $386.11 · Option exercise (M): 1,152 @ $0 · Tax withholding (F): 485 @ $386.11 · Grant/award (A): 4,313 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 moreEDGAR
2026-09-094EVRAN SEDAT — EVP, Global Supply ChainOption exercise (M): 1,027 @ $0 · Tax withholding (F): 329 @ $386.11 · Option exercise (M): 864 @ $0 · Tax withholding (F): 277 @ $386.11 · Grant/award (A): 4,026 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 moreEDGAR
2026-09-094SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% ownerOption exercise (M): 4,109 @ $0 · Tax withholding (F): 2,876 @ $386.11 · Option exercise (M): 3,455 @ $0 · Tax withholding (F): 1,854 @ $386.11 · Grant/award (A): 17,251 (derivative) @ $0 · Option exercise (M): 4,109 (derivative) @ $0 · +1 moreEDGAR
2026-09-034SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% ownerOption exercise (M): 5,087 @ $0 · Tax withholding (F): 2,336 @ $380.96 · Option exercise (M): 2,082 (derivative) @ $0 · Option exercise (M): 3,005 (derivative) @ $0EDGAR
2026-09-034Allison Schwartz — DirectorOption exercise (M): 117 @ $0 · Tax withholding (F): 43 @ $380.96 · Option exercise (M): 42 (derivative) @ $0 · Option exercise (M): 75 (derivative) @ $0EDGAR
2026-09-034BARRY JAMES — EVP, President, LSGOption exercise (M): 425 @ $0 · Tax withholding (F): 154 @ $380.96 · Option exercise (M): 174 (derivative) @ $0 · Option exercise (M): 251 (derivative) @ $0EDGAR
2026-07-284ENGELHARDT EVA ANETTE — EVP, President, CDGOption exercise (M): 246 @ $0 · Tax withholding (F): 89 @ $314.46 · Option exercise (M): 246 (derivative) @ $0EDGAR
2026-05-134ENGELHARDT EVA ANETTE — EVP, President, CDGSale (S): 550 @ $246.54EDGAR
2026-04-284ENLOE COURTNEY C — EVP, General Counsel & SecOption exercise (M): 186 @ $0 · Tax withholding (F): 77 @ $287.84 · Option exercise (M): 186 (derivative) @ $0EDGAR
2026-04-284Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerOption exercise (M): 1,078 @ $0 · Tax withholding (F): 420 @ $287.84 · Option exercise (M): 1,078 (derivative) @ $0EDGAR
2026-04-234PEI MELINDA LITHERLAND — DirectorOption exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0EDGAR
2026-04-234PINKSTON ARNOLD A — DirectorOption exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0EDGAR
2026-04-234Hinckley Greg K — DirectorOption exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0EDGAR
2026-04-234EDWARDS JEFFREY L — DirectorOption exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0EDGAR
2025-11-104BARRY JAMES — EVP, President, LSGSale (S): 699.87 @ $306.18EDGAR
2025-10-284DiVincenzo Jonathan P. — President & COOOption exercise (M): 1,869 @ $0 · Tax withholding (F): 950 @ $339.75 · Option exercise (M): 1,869 (derivative) @ $0EDGAR
2025-10-214EVRAN SEDAT — EVP, Global Supply ChainOption exercise (M): 1,044 @ $0 · Tax withholding (F): 335 @ $321.90 · Option exercise (M): 1,044 (derivative) @ $0EDGAR
2025-09-094Mehta Rajat — EVP, GBL Commercial OperationsGrant/award (A): 1,827 (derivative) @ $0 · Grant/award (A): 5,480 (derivative) @ $0EDGAR
2025-09-094ENGELHARDT EVA ANETTE — EVP, President, CDGOption exercise (M): 1,152 @ $0 · Tax withholding (F): 413 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 1,152 (derivative) @ $0EDGAR
2025-09-094BARRY JAMES — EVP, President, LSGOption exercise (M): 1,056 @ $0 · Tax withholding (F): 378 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 1,056 (derivative) @ $0EDGAR
2025-09-094ENLOE COURTNEY C — EVP, General Counsel & SecOption exercise (M): 768 @ $0 · Tax withholding (F): 275 @ $295.43 · Grant/award (A): 2,740 (derivative) @ $0 · Option exercise (M): 768 (derivative) @ $0EDGAR
2025-09-094EVRAN SEDAT — EVP, Global Supply ChainOption exercise (M): 864 @ $0 · Tax withholding (F): 277 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 864 (derivative) @ $0EDGAR
2025-09-094COREY COLLEEN — EVP, Global Human ResourcesOption exercise (M): 576 @ $0 · Tax withholding (F): 209 @ $295.43 · Grant/award (A): 2,740 (derivative) @ $0 · Option exercise (M): 576 (derivative) @ $0EDGAR
2025-09-094Allison Schwartz — DirectorOption exercise (M): 92 @ $0 · Tax withholding (F): 33 @ $295.43 · Grant/award (A): 914 (derivative) @ $0 · Option exercise (M): 92 (derivative) @ $0EDGAR
2025-09-094DiVincenzo Jonathan P. — President & COOGrant/award (A): 6,850 (derivative) @ $0EDGAR
2025-09-094Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerOption exercise (M): 1,535 @ $0 · Tax withholding (F): 550 @ $295.43 · Grant/award (A): 5,480 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2025-09-094SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% ownerOption exercise (M): 3,455 @ $0 · Tax withholding (F): 1,528 @ $295.43 · Grant/award (A): 16,439 (derivative) @ $0 · Option exercise (M): 3,455 (derivative) @ $0EDGAR
2025-09-034BARRY JAMES — EVP, President, LSGOption exercise (M): 602 @ $0 · Tax withholding (F): 217 @ $297.88 · Option exercise (M): 178 (derivative) @ $0 · Option exercise (M): 174 (derivative) @ $0 · Option exercise (M): 250 (derivative) @ $0EDGAR
2025-09-034COREY COLLEEN — EVP, Global Human ResourcesOption exercise (M): 1,102 @ $0 · Tax withholding (F): 398 @ $297.88 · Option exercise (M): 254 (derivative) @ $0 · Option exercise (M): 347 (derivative) @ $0 · Option exercise (M): 501 (derivative) @ $0EDGAR
2025-09-034Allison Schwartz — DirectorOption exercise (M): 147 @ $0 · Tax withholding (F): 55 @ $297.88 · Option exercise (M): 31 (derivative) @ $0 · Option exercise (M): 42 (derivative) @ $0 · Option exercise (M): 74 (derivative) @ $0EDGAR
2025-09-034SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% ownerOption exercise (M): 6,353 @ $0 · Tax withholding (F): 3,084 @ $297.88 · Option exercise (M): 1,266 (derivative) @ $0 · Option exercise (M): 2,082 (derivative) @ $0 · Option exercise (M): 3,005 (derivative) @ $0EDGAR
2025-07-294ENGELHARDT EVA ANETTE — EVP, President, CDGOption exercise (M): 245 @ $0 · Tax withholding (F): 88 @ $264.19 · Option exercise (M): 245 (derivative) @ $0EDGAR
2025-04-244PINKSTON ARNOLD A — DirectorOption exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0EDGAR
2025-04-244PEI MELINDA LITHERLAND — DirectorOption exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0EDGAR
2025-04-244HINCKLEY GREGORY K — DirectorOption exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0EDGAR
2025-04-244EDWARDS JEFFREY L — DirectorOption exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0EDGAR
2025-03-184Crowley Michael — EVP, GBL Commercial OperationsOption exercise (M): 3,000 @ $159.32 · Sale (S): 3,000 @ $247.06 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2025-03-054EVRAN SEDAT — EVP, Global Supply ChainGrant/award (A): 2,918 (derivative) @ $0EDGAR
2025-03-054DiVincenzo Jonathan P. — President & COOGrant/award (A): 4,863 (derivative) @ $0EDGAR

Recent 8-K events — BIO-RAD LABORATORIES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-198-K7.01 — Regulation FD DisclosureEDGAR
2026-02-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-298-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-308-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-318-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BIO.B returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs